The proposed model achieves 98.48% accuracy in classifying pulmonary disorders like COVID-19 and pneumonia, indicating its potential in clinical settings.
Respiratory infections such as COVID-19, tuberculosis (TB) and pneumonia, remain important global health challenges, often requiring rapid and accurate diagnosis to prevent complications. Due to the visual similarities in chest X-ray (CXR) images, distinguishing between these diseases can be complex. In this study, we proposed, a deep learning (DL)-based model utilizing a customized VGG-19 architecture for multiclass classification of lung diseases, including COVID-19, pneumonia, TB, and healthy cases. A total of 5,928 CXR images were collected from open-access platforms, comprising COVID-19, pneumonia, TB, and normal cases. The dataset was pre-processed using bilateral filtering for noise suppression and Multiscale Retinex for image enhancement. FFurthermore, data augmentation and image resizing were also applied to increase robustness. When compared with the state-of-the-art techniques, the proposed method achieved a classification accuracy of 98.48% in identifying various lung disorders, with precision at 97% and an F1-score of 96%, indicating that it is an appropriate technique for computerized lung disease diagnosis in clinical environments.
No takes yet. Share an insight, caveat, or question.
Vazralu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: